Consun Pharmaceutical Group Limited (HKG:1681)
Hong Kong · Delayed Price · Currency is HKD 13.69
-0.01 (-0.07%)
Jul 31, 2026, 4:08 PM HKT
HKG:1681 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 3,417 | 3,417 | 2,967 | 2,590 | 2,340 | 2,045 |
Revenue Growth | 4.59% | 15.17% | 14.56% | 10.71% | 14.43% | 16.65% |
Gross Profit Gross Profit Growth | 2,667 | 2,667 | 2,242 | 1,922 | 1,763 | 1,527 |
Operating Income Operating Income Growth | 1,152 | 1,152 | 974.99 | 825.92 | 715.41 | 660.18 |
Net Income Net Income Growth | 1,078 | 1,078 | 910.46 | 784.53 | 682.91 | 590.17 |
Earnings Per Share EPS Growth | 1.26 | 1.26 | 1.09 | 0.98 | 0.86 | 0.73 |
EPS Growth | 7.03% | 15.60% | 11.22% | 13.95% | 17.81% | 19.67% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Consun Pharmaceutical Segment Consun Pharmaceutical Segment Growth | 2,967 | 2,967 | 2,532 | 2,195 | 1,981 | 1,733 |
Yulin Pharmaceutical Segment Yulin Pharmaceutical Segment Growth | 473.11 | 473.11 | 442.84 | 395.06 | 358.6 | 311.68 |
Elimination of Inter-segment Elimination of Inter-segment Growth | -22.25 | -22.25 | -7.12 | - | - | - |
Total Total Growth | 3,417 | 3,417 | 2,967 | 2,590 | 2,340 | 2,045 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 3,903 | 3,903 | 3,866 | 3,583 | 3,039 | 2,426 |
Total Debt Total Debt Growth | 212.92 | 212.92 | 267.17 | 511.53 | 460.18 | 610.97 |
Net Cash (Debt) Net Cash Growth | 3,691 | 3,691 | 3,599 | 3,072 | 2,579 | 1,815 |
Net Cash Growth | -2.47% | 2.56% | 17.15% | 19.10% | 42.08% | 30.52% |
Net Cash Per Share Net Cash Per Share Growth | 4.32 | 4.32 | 4.32 | 3.84 | 3.26 | 2.26 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 1,212 | 1,212 | 1,087 | 818.97 | 947.68 | 725.54 |
Capital Expenditures CapEx Growth | -68.48 | -68.48 | -109 | -52.56 | -51.59 | -98.25 |
Free Cash Flow Free Cash Flow Growth | 1,143 | 1,143 | 977.99 | 766.41 | 896.09 | 627.29 |
Free Cash Flow Growth | 0.02% | 16.91% | 27.61% | -14.47% | 42.85% | -23.35% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 78.05% | 78.05% | 75.56% | 74.19% | 75.35% | 74.70% |
Operating Margin | 33.71% | 33.71% | 32.86% | 31.89% | 30.58% | 32.29% |
Pretax Margin | 35.01% | 35.01% | 34.38% | 33.35% | 31.90% | 34.03% |
Profit Margin | 31.55% | 31.55% | 30.68% | 30.29% | 29.19% | 28.86% |
FCF Margin | 33.46% | 33.46% | 32.96% | 29.59% | 38.30% | 30.68% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.800 | 0.656 | 0.564 | 0.408 | 0.265 | 0.244 |
Dividend Per Share Growth | -36.51% | 16.35% | 38.03% | 53.92% | 8.58% | 3.66% |
Dividend Yield | 5.84% | 4.80% | 7.94% | 11.85% | 10.18% | 9.86% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 9.76 | 10.95 | 6.99 | 4.37 | 4.14 | 4.82 |
Forward PE | 8.01 | 9.81 | 6.57 | 4.09 | 4.18 | 3.80 |
P/FCF Ratio | 9.03 | 10.33 | 6.51 | 4.48 | 3.15 | 4.54 |
PS Ratio | 3.02 | 3.46 | 2.14 | 1.33 | 1.21 | 1.39 |